Enfermedades Sistémicas de Base Autoinmune

Michelsen, B; Ostergaard, M; Nissen, MJ; Ciurea, A; Möller, B; Ornbjerg, LM; Horák, P; Glintborg, B; Macdonald, A; Laas, K; Sokka-Isler, T; Gudbjornsson, B; Iannone, F; Hellamand, P; Kvien, TK; Rodrigues, AM; Codreanu, C; Rotar, Z; Castrejón, I; Wallman, JK; Pavelka, K; Loft, AG; Heddle, M; Vorobjov, S; Relas, H; Gröndal, G; Gremese, E; van der Horst-bruinsma, I; Kristianslund, EK; Santos, MJ; Mogosan, C; Tomsic, M; Diaz-Gonzalez, F; Di Giuseppe, D; Nielsen, SW; Hetland, ML.

Disparities in the organisation of national healthcare systems for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe

HEALTH POLICY. 2025; 156: [doi:10.1016/j.healthpol.2025.105311]

Almaraz, ER; Salman-Monte, TC; Calvo-Alen, J; Ajo, MJB; Alvaro, JMAG; Bernabeu, P; Blasco, JB; Ortega, SP; Renau, RR; Marsinach, CS; Galvez-Fernandez, M; Bahamontes-Rosa, N; Hernández, JSC; Izquierdo, MG.

Doctor-patient communication in Systemic Lupus Erythematosus: Insights from the LupusVoice study

Ssm-Qualitative Research In Health. 2025; 7: Nº de citas: 1 [doi:10.1016/j.ssmqr.2025.100528]

Boteanu, A; Bethencourt, JJ; Calzada-Hernández, J; Clemente, D; Nieto-González, JC; López, C; Luque, L; Calvo, I.

Management of childhood-onset systemic lupus erythematosus (cSLE) over the last two decades in Spain

Pediatric Rheumatology. 2025; 23(1): [doi:10.1186/s12969-025-01113-3]

Galíndez-Agirregoikoa, E; Prieto-Peña, D; García-Vivar, ML; Otano, JMB; Joven-Ibáñez, B; Vergara-Dangond, C; Pavía-Pascual, M; Urionaguena-Onaindia, I; Alvarez, LV; Larrubia, MAP; Giráldez, CR; Garcia-Vicuña, R; Jovani, V; Martínez-Ferrer, A; Martínez-Losa, MM; Hernández, TG; González, RA; Urruticoechea-Arana, A; Macía-Villa, C; Gorostiza, I; Alonso, RB.

Treatment with Upadacitinib in Difficult-to-Treat (D2T) Psoriatic Arthritis (PsA): A National Multicenter Study of the First 134 Patients in Clinical Practice

Sci. 2025; 7(2): [doi:10.3390/sci7020067]

Vela-Casasempere, P; Otero-Varela, L; Sabater, SG; Alameda, RC; Fernández, CC; Calvo-Gutiérrez, J; Pérez-Vera, Y; Arija, SM; Bustabad, S; Ruiz, JM; Montesino, MDR; Gutiérrez, LR; Varela, AM; Ramos, MJM; Sánchez-Alonso, F; Castrejón, I.

Gender differences in clinical and prescribing characteristics of biologic and targeted synthetic drugs in naïve patients with rheumatoid arthritis: Data from BIOBADASER III registry

ARTHRITIS RESEARCH & THERAPY. 2025; 27(1): [doi:10.1186/s13075-025-03571-2]

López-Medina, C; Otero-Varela, L; Sánchez-Alonso, F; Jovaní, V; Expósito-Pérez, L; Melchor-Díaz, S; Pérez-Vera, Y; Pretel-Ruiz, P; Manero, J; Mera-Varela, A; Mateo, L; Ruiz-Montesino, D; Lorenzo-Martín, JA; Pedraz-Penalva, T; Castrejón, I.

One-year retention rate of ixekizumab in patients with psoriatic arthritis and axial spondyloarthritis: Real-world data from the BIOBADASER registry

Reumatologia Clinica. 2025; 21(5): [doi:10.1016/j.reuma.2025.501872]

Pons, M; Georgiadis, S; Ostergaard, M; Ahmadzay, ZF; Glintborg, B; Heberg, J; Christensen, SN; Rasmussen, S; Loft, AG; Castrejón, I; Sánchez-Alonso, F; Iannone, F; Nordström, D; Hokkanen, AM; Ciurea, A; Nissen, MJ; Závada, J; Pavelka, K; Rotar, Z; Pirkmajer, KP; Michelsen, B; Mielnik, P; Bernardes, M; Khmelinskii, N; Laas, K; Vorobjov, S; Codreanu, C; Macfarlane, GJ; Jones, GT; Gudbjornsson, B; Palsson, O; Wallman, JK; van der Horst-bruinsma, I; Onen, F; Hetland, ML; Ornbjerg, LM.

Four-year secukinumab treatment outcomes in European real-world patients with axial spondyloarthritis and psoriatic arthritis

JOINT BONE SPINE. 2025; 92(3): Nº de citas: 1 [doi:10.1016/j.jbspin.2024.105824]

Clemente, D; Leon, L; Nieto-Gonzalez, JC; Boteanu, AL; Folguera, LT; García-Fernández, AA; Muñoz, HA; Palomeque, A; Robledillo, JCL; Abasolo, L.

Incidence and reasons for biologic and targeted synthetic DMARD switching in juvenile idiopathic arthritis: a real- life stratified analysis

Pediatric Rheumatology. 2025; 23(1): Nº de citas: 1 [doi:10.1186/s12969-025-01097-0]

Chamorro-de-Vega, E; González, CM; Menchén, L; Baniandrés, O; Herranz, A; Lobo-Rodríguez, C; Romero-Jiménez, R; Ais-Larisgoitia, A; Lobato-Matilla, E; López-Esteban, A; López-Calleja, A; Marín-Jiménez, I; Monteagudo, I; de los Rios, PM; Nieto, JC; Ferris-Villanueva, M; Lizcano, MJ; Moreno, MPS; Sanjurjo, M; De Sanjose, SG.

New Model of Integrated Care for Patients with Immune-Mediated Inflammatory Diseases

INTERNATIONAL JOURNAL OF INTEGRATED CARE. 2025; 25(2): [doi:10.5334/ijic.7741]

Sangüesa, C; Olivé, A; Rúa-Figueroa, I; González, IA; Martinez-Barrio, J; Galindo-Izquierdo, M; Alén, JC; Isacelaya, EU; Muriel, ET; González, MF; Martínez-Taboada, V; Salgado-Pérez, E; Vela, P; Fernández-Nebro, A; Narváez, J; Almagro, RM; Soler, GS; Novoa, J; Pecondón, A; Aguinaga, EA; Ibarguengoitia, O; Morales, CM; Hernán, GB; Torrente-Segarra, V; Monte, TCS; Barceló, MI; García-Villanueva, MJ; Alameda, RC; Fontonova, JC; Rodríguez, TRV; Vila, VQ; Expósito, L; Moreira, V; Sánchez, JLA; Romero, BP; Morales, CM; Horcada, L; Lozano-Rivas, N; Gómez, AP; Pego-Reigosa, JM.

Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La

LUPUS. 2025; 34(6): 571-578 [doi:10.1177/09612033251331249]

Amar Muñoz HM; Molina-Collada J; Castrejón I; Monjo-Henry I; Fernández-Fernández E; Álvaro-Gracia JM; de Miguel E.

Different giant cell arteritis phenotypes may present distinct types of ischaemic complications.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2025; 43(4): 668-673 Nº de citas: 1 [doi:10.55563/clinexprheumatol/kexxzi]

Lovgach, OR; Plaza, Z; Castro, MF; Rosas, J; Martínez-Taboada, V; Olivé, A; Almagro, RM; Benavente, BS; Font-Urgelles, J; Garcia-Aparicio, A; Manrique-Arija, S; Garcia-Vadillo, A; Lopez-Gonzalez, R; Garcia, JN; Rodriguez-Lozano, MB; Galiste, C; Gonzalez-Martin, JJ; Vela-Casasempere, P; Bohorquez, C; Erausquin, C; Paredes-Romero, MB; Riancho-Zarrabeitia, L; Diaz, SM; Pego-Reigosa, JM; Heredia, S; Moriano, C; Cañamero, MAB; Estrada, P; Judez, E; Otano, JB; Giráldez, CR; Dominguez-Alvaro, M; Alonso, FS; Sánchez, JLA.

Mortality in Patients With Sjögren Disease: A Prospective Cohort Study Identifying Key Predictors

JOURNAL OF RHEUMATOLOGY. 2025; 52(3): 257-262 [doi:10.3899/jrheum.2024-1033]

Martín-Gutiérrez, A; Molina-Collada, J; Domínguez-Alvaro, M; Melero-González, RB; Fernández-Fernánde, E; Silva-Diaz, M; Valero, JA; González, I; Martín, JS; Narváez, J; Calvo, I; Aldasoro, V; Alcázar, LA; Loricera, J; Ruíz-Roman, A; Castañeda, S; Molina-Almela, C; Villar, MA; Mas, AJ; Blanco, R; ARTESER Project Collaborat Grp.

Cerebrovascular accidents in giant cell arteritis: prevalence and predictive factors from the ARTESER registry

RHEUMATOLOGY. 2025; 64(6): 3733-3738 [doi:10.1093/rheumatology/keaf051]

Martínez-Lozano, H; Saralegui-Gonzalez, P; Reigadas, E; Fueyo-Peláez, PR; García-García, A; Miranda-Bautista, J; Alcalá, L; Nieto, JC; Lobato-Matilla, ME; Marín-Jiménez, I; Muñoz, P; Menchén, L.

Risk factors for Clostridioides difficile infection among patients diagnosed with inflammatory intestinal and rheumatological diseases in the biologic era

BMC GASTROENTEROLOGY. 2025; 25(1): Nº de citas: 1 [doi:10.1186/s12876-025-03650-3]

Ciurea, A; Kissling, S; Götschi, A; Ornbjerg, LM; Rasmussen, SH; Tamási, B; Möller, B; Nissen, MJ; Glintborg, B; Loft, AG; Scherer, A; Bräm, R; Pavelka, K; Závada, J; Dias, JM; Valente, P; Gudbjornsson, B; Palsson, O; Rantalaiho, V; Peltomaa, R; Codreanu, C; Mogosan, C; Iannone, F; Sebastiani, M; Jones, GT; Macfarlane, GJ; Castrejon, I; Rotar, Z; Michelsen, B; Wallman, JK; van der Horst-bruinsma, I; Distler, O; Ostergaard, M; Hetland, ML; Micheroli, R; Ospelt, C.

Differences in the response to TNF inhibitors at distinct joint locations in patients with psoriatic arthritis: results from nine European registries

ARTHRITIS RESEARCH & THERAPY. 2025; 27(1): Nº de citas: 2 [doi:10.1186/s13075-025-03488-w]

Cobo-Ibáñez, T; Castellví, I; Pros, A; Domínguez-Alvaro, M; Nuño-Nuño, L; Martínez-Barrio, J; Jovaní, V; Romero-Bueno, F; Ruiz-Lucea, E; Tomero, E; Trallero-Araguás, E; Narváez, J; Camins-Fàbregas, J; Ruiz-Román, A; Loarce-Martos, J; Holgado-Pérez, S; Flores-Rodríguez, VM; Sivera, F; Merino-Argumanez, C; Juan-Mas, A; Altabás-González, I; Martín-López, M; Belzunegui-Otano, JM; Carrasco-Cubero, C; Freire-González, M; Rua-Figueroa, I; Lozano-Rivas, N; Suarez-Cuba, JD; Martínez, O; Ortega-Castro, R; Alcocer, P; Gómez-Gómez, A; Sánchez-Pernaute, O; Tandaipan, JL; Carrión-Barberà, I; Plasencia-Rodríguez, C; Ibarguengoitia-Barrena, O; Vidal-Montal, P; Ortiz-Santamaria, V; Garrido-Puñal, N; Riveros, A; Delgado-Frías, E; López-Gómez, JM; Barbadillo, C; Pego-Reigosa, JM; Joven-Ibáñez, BE; Valero-Jaimes, JA; Naveda, E; Turrión-Nieves, AI; Seoane-Mato, D; Prado-Galbarro, FJ; Puche-Larrubia, MA.

Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry

ARTHRITIS RESEARCH & THERAPY. 2025; 27(1): [doi:10.1186/s13075-024-03471-x]

Molina-Collada, J; Domínguez-Alvaro, M; Melero-González, RB; de Miguel, E; Silva-Díaz, M; Jaimes, JAV; González, I; Martín, JS; Narváez, J; Calvet, J; Casafont-Solé, I; Ivorra, JAR; Arrabal, SL; Rocha, MV; Iñiguez, CL; Reyes, MSB; Fernández, CC; Villar, MA; Mas, AJ; Blanco, R; ARTESER Project Collaborative Grp.

Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry

ARTHRITIS RESEARCH & THERAPY. 2025; 27(1): [doi:10.1186/s13075-024-03468-6]

Bourgeois, C; Sánchez-Lucas, M; Olmedo-Galindo, J; Schiaffino, MT; del Río, T; Molina-Collada, J; Martínez-Barrio, J; Fernández-Plana, G; Rivera, J; Alvaro-Gracia, JM; Castrejon, I.

Improving early referrals for inflammatory arthritis through primary care engagement: a quality improvement initiative

Rheumatology Advances In Practice. 2025; 9(4): [doi:10.1093/rap/rkaf129]